Literature DB >> 15263834

Gene profile changes after Pseudomonas aeruginosa exposure in immortalized airway epithelial cells.

Aura Perez1, Pamela B Davis.   

Abstract

To test the hypothesis that the excess inflammatory response in cystic fibrosis airway epithelial cells is the result of differential activation of genes in response to a laboratory strain of Pseudomonas aeruginosa (PAO1), a 48-h time course of genes expressed following PAO1 stimulation (10(9) CFU for 1 h) was studied in two pairs of airway epithelial cells: 9/HTEo- and 16HBE14o-, each with a matched normal and CF phenotype pair. cRNA was hybridized to Affymetrix HG-U95Av2 chips and pairwise comparisons against zero time (no PAO1) were calculated for each time point. PAO1 elicited profound changes in both cell pairs: for 9/HTEo-, 144 genes changed significantly in the normal pair, and 116 for the CF pair; for the 16HBE14o- pair, 57 genes changed significantly for the normal pair and 53 for the CF pair. Changes were much greater in the 9/HTEo- than in the 16HBE14o- pair, but basal levels of expression of inflammatory genes are higher in the 16HBE14o- pair, so 16HBE14o- was used mainly to corroborate the results of 9/HTEo-. Clustering analysis indicated that the pattern of gene expression is similar in the CF cells and their normal counterparts. However, there were substantial quantitative differences in gene expression. Thus, the difference between CF and normal resides in the magnitude, not the pattern, of the changes.

Entities:  

Mesh:

Year:  2004        PMID: 15263834     DOI: 10.1023/B:JSFG.0000028982.59273.bd

Source DB:  PubMed          Journal:  J Struct Funct Genomics        ISSN: 1345-711X


  13 in total

1.  The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production.

Authors:  Alayne Cuzick; Fiona R Stirling; Susan L Lindsay; Thomas J Evans
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Genetic variation and clinical heterogeneity in cystic fibrosis.

Authors:  Mitchell L Drumm; Assem G Ziady; Pamela B Davis
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

3.  Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells.

Authors:  Nina Reiniger; Jeffrey K Ichikawa; Gerald B Pier
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  β-arrestin-2 regulation of the cAMP response element binding protein.

Authors:  Mary E Manson; Deborah A Corey; Sharon M Rymut; Thomas J Kelley
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

5.  Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells?

Authors:  Thomas H Hampton; Alicia E Ballok; Jennifer M Bomberger; Melanie R Rutkowski; Roxanna Barnaby; Bonita Coutermarsh; José R Conejo-Garcia; George A O'Toole; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-20       Impact factor: 5.464

6.  Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3.

Authors:  Michel Fausther; Julie Pelletier; Carla M Ribeiro; Jean Sévigny; Maryse Picher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-26       Impact factor: 5.464

7.  Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.

Authors:  Aric L Gregson; Xiaoyan Wang; S Sam Weigt; Vyacheslav Palchevskiy; Joseph P Lynch; David J Ross; Bernard M Kubak; Rajan Saggar; Michael C Fishbein; Abbas Ardehali; Gang Li; Robert Elashoff; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

8.  Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling.

Authors:  Mairi J Hunter; Kate J Treharne; Alexandra K Winter; Diane M Cassidy; Stephen Land; Anil Mehta
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

9.  Pseudomonas aeruginosa Inhibition of Flagellin-activated NF-kappaB and interleukin-8 by human airway epithelial cells.

Authors:  Jose Pena; Zhu Fu; Christian Schwarzer; Terry E Machen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

10.  Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium.

Authors:  Aura Perez; Anna M van Heeckeren; David Nichols; Sanhita Gupta; Jean F Eastman; Pamela B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-13       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.